Deletion of the GI-2 integrase and the wbkA flanking transposase improves the stability of Brucella melitensis Rev 1 vaccine

Veterinary Research

Volumn 44, Issue 1, 2013, Pages

  Mancilla, Marcos ^a,b   Grilló, María Jesús ^c   De Miguel, María Jesús ^d   López Goñi, Ignacio ^a   San Román, Beatriz ^c   Zabalza Baranguá, Ana ^c   Moriyón, Ignacio ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSIDAD AUSTRAL DE CHILE   (Chile)

^c INSTITUTO DE AGROBIOTECNOLOGÍA   (Spain)

^d Instituto Agroalimentario de Aragón IA2   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BACTERIAL VACCINE; GLYCOSYLTRANSFERASE; INTEGRASE;

ANIMAL; ANIMAL DISEASE; ARTICLE; BACTERIAL CHROMOSOME; BAGG ALBINO MOUSE; BRUCELLA MELITENSIS; BRUCELLOSIS; CYTOLOGY; DNA SEQUENCE; ENZYMOLOGY; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION; GENETICS; GENOMIC ISLAND; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; MOUSE; MUTAGENESIS; POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING;

ANIMALS; BACTERIAL PROTEINS; BACTERIAL VACCINES; BLOTTING, SOUTHERN; BRUCELLA MELITENSIS; BRUCELLOSIS; CHROMOSOMES, BACTERIAL; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION, BACTERIAL; GENOMIC ISLANDS; GLYCOSYLTRANSFERASES; INTEGRASES; MICE; MICE, INBRED BALB C; MUTAGENESIS; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA;

EID: 84887839337     PISSN: 09284249     EISSN: 12979716     Source Type: Journal    
DOI: 10.1186/1297-9716-44-105     Document Type: Article

References (38)

1. Mapping of poverty and likely zoonoses hotspots. Grace D, Mutua F, Ocungo P, Kruska R, Jones K, Brierley L, Lapar L, Said M, Herrero M, Duc Phuc P, Elich Tao N, Akuku I, Ogutu F, Zoonoses Project 2012 4 1 119
2. Anonymous, The control of Neglected Zoonoses Diseases: A route to poverty alleviation Geneva: WHO Press 2006
3. A review of the use of B. melitensis Rev 1 vaccine in adult sheep and goats. Blasco JM, Prev Vet Med 1997 31 275 283 10.1016/S0167-5877(96)01110-5 9234451 (Pubitemid 127378504)
4. Rough vaccines in animal brucellosis: structural and genetic basis and present status. Moriyón I, Grilló MJ, Monreal D, González D, Marín C, Lopez-Goñi I, Mainar-Jaime RC, Moreno E, Blasco JM, Vet Res 2004 35 1 38 10.1051/vetres:2003037 15099501 (Pubitemid 38380146)
5. Rough mutants defective in core and O-polysaccharide synthesis and export induce antibodies reacting in an indirect ELISA with smooth lipopolysaccharide and are less effective than Rev 1 vaccine against Brucella melitensis infection of sheep. Barrio MB, Grilló MJ, Muñoz PM, Jacques I, González D, De-Miguel MJ, Marín CM, Barberan M, Letesson JJ, Gorvel JP, Moriyón I, Blasco JM, Zygmunt MS, Vaccine 2009 27 1741 1749 10.1016/j.vaccine.2009.01.025 19186196
6. Brucellosis at the animal/ecosystem/human interface at the beginning of the 21st century. Godfroid J, Scholz HC, Barbier T, Nicolas C, Wattiau P, Fretin D, Whatmore AM, Cloeckaert A, Blasco JM, Moriyón I, Saegerman C, Muma JB, Al-Dahouk S, Neubauer H, Letesson JJ, Prev Vet Med 2011 102 118 131 10.1016/j.prevetmed.2011.04.007 21571380
7. The "effects" of Rev-1 vaccination of sheep and goats on human brucellosis in Greece. Minas A, Minas M, Stournara A, Tselepidis S, Prev Vet Med 2004 64 41 47 10.1016/j.prevetmed.2004.03.007 15219968 (Pubitemid 38847906)
8. Alton GG, Jones LM, Angus RD, Verger JM, Techniques for the brucellosis laboratory Paris, France: INRA 1988
9. Brucellosis vaccines: assessment of Brucella melitensis lipopolysaccharide rough mutants defective in core and O-polysaccharide synthesis and export. González D, Grilló MJ, De-Miguel MJ, Ali T, Arce-Gorvel V, Delrue RM, Conde-Álvarez R, Muñoz PM, Lopez-Goñi I, Iriarte M, Marín CM, Weintraub A, Widmalm G, Zygmunt M, Letesson JJ, Gorvel JP, Blasco JM, Moriyón I, PLoS One 2008 3 2760 10.1371/journal.pone.0002760 18648644
10. Genomic Island 2 is an unstable genetic element contributing to Brucella lipopolysaccharide spontaneous smooth-to-rough dissociation. Mancilla M, Lopez-Goñi I, Moriyón I, Zarraga AM, J Bacteriol 2010 192 6346 6351 10.1128/JB.00838-10 20952568
11. DNA polymorphism in the omp25/omp31 family of Brucella spp.: identification of a 1.7-kb inversion in Brucella cetaceae and of a 15.1-kb genomic island, absent from Brucella ovis, related to the synthesis of smooth lipopolysaccharide. Vizcaíno N, Caro-Hernandez P, Cloeckaert A, Fernandez-Lago L, Microbes Infect 2004 6 821 834 10.1016/j.micinf.2004.04.009 15374004
12. Restriction site polymorphisms in the genes encoding new members of group 3 outer membrane protein family of Brucella spp. García-Yoldi D, Marín CM, Lopez-Goñi I, FEMS Microbiol Lett 2005 245 79 84 10.1016/j.femsle.2005.02.026 15796983 (Pubitemid 40410680)
13. The lipopolysaccharide core of Brucella abortus acts as a shield against innate immunity recognition. Conde-Álvarez R, Arce-Gorvel V, Iriarte M, Mancek-Keber M, Barquero-Calvo E, Palacios-Chaves L, Chacón-Díaz C, Chaves-Olarte E, Martirosyan A, Von-Bargen K, Grilló MJ, Jerala R, Brandenburg K, Llobet E, Bengoechea JA, Moreno E, Moriyón I, Gorvel JP, PLoS Pathog 2012 8 1002675 10.1371/journal.ppat.1002675 22589715
14. Spontaneous excision of the O-polysaccharide wbkA glycosyltranferase gene is a cause of dissociation of smooth to rough Brucella colonies. Mancilla M, Marín CM, Blasco JM, Zarraga AM, Lopez-Goñi I, Moriyón I, J Bacteriol 2012 194 1860 1867 10.1128/JB.06561-11 22328663
15. Lipopolysaccharide-deficient Brucella variants arise spontaneously during infection. Turse JE, Pei J, Ficht TA, Front Microbiol 2011 2 54 21833310
16. Identification of an IS711 element interrupting the wboA gene of Brucella abortus vaccine strain RB51 and a PCR assay to distinguish strain RB51 from other Brucella species and strains. Vemulapalli R, McQuiston JR, Schurig GG, Sriranganathan N, Halling SM, Boyle SM, Clin Diagn Lab Immunol 1999 6 760 764 10473532 (Pubitemid 29441188)
17. DNA polymorphism analysis of Brucella lipopolysaccharide genes reveals marked differences in O-polysaccharide biosynthetic genes between smooth and rough Brucella species and novel species-specific markers. Zygmunt MS, Blasco JM, Letesson JJ, Cloeckaert A, Moriyón I, BMC Microbiol 2009 9 92 10.1186/1471-2180-9-92 19439075
18. The genome sequence of the facultative intracellular pathogen Brucella melitensis. DelVecchio VG, Kapatral V, Redkar RJ, Patra G, Mujer C, Los T, Ivanova N, Anderson I, Bhattacharyya A, Lykidis A, Reznik G, Jablonski L, Larsen N, D'Souza M, Bernal A, Mazur M, Goltsman E, Selkov E, Elzer PH, Hagius S, O'Callaghan D, Letesson JJ, Haselkorn R, Kyrpides N, Overbeek R, Proc Natl Acad Sci USA 2002 99 443 448 10.1073/pnas.221575398 11756688 (Pubitemid 34060380)
19. National Center for Biotechnology Information/Basic Local Aligment Search Tool (NCBI/BLAST). [ http://www.ncbi.nlm.nih.gov/BLAST ]
20. European Molecular Biology Laboratory-European Bioinformatics Institute (EMBI-EBI). [ http://www.ebi.ac.uk/Tools/clustalo ]
21. National Center for Biotechnology Information/Primer-BLAST (NCBI/Primer-BLAST). [ http://www.ncbi.nlm.nih.gov/tools/primer-blast/ ]
22. Preparation of genomic DNA from bacteria. Wilson K, Curr Protoc Mol Biol 1997 2.4.1 2.4.5
23. Development of a new PCR assay to identify Brucella abortus biovars 5, 6 and 9 and the new subgroup 3b of biovar 3. Ocampo-Sosa AA, Aguero-Balbin J, Garcia-Lobo JM, Vet Microbiol 2005 110 41 51 10.1016/j.vetmic.2005.06.007 16029934 (Pubitemid 41265834)
24. Brucella melitensis Rev.1 living attenuated vaccine: stability of markers, residual virulence and immunogenicity in mice. Bosseray N, Biologicals 1991 19 355 363 10.1016/S1045-1056(05)80025-9 1797046
25. In vitro markers and biological activity in mice of seed lot strains and commercial Brucella melitensis Rev 1 and Brucella abortus B19 vaccines. Grilló MJ, Bosseray N, Blasco JM, Biologicals 2000 28 119 127 10.1006/biol.2000.0249 10885618
26. Synthesis of phosphatidylcholine, a typical eukaryotic phospholipid, is necessary for full virulence of the intracellular bacterial parasite Brucella abortus. Conde-Álvarez R, Grilló MJ, Salcedo SP, De-Miguel MJ, Fugier E, Gorvel JP, Moriyón I, Iriarte M, Cell Microbiol 2006 8 1322 1335 10.1111/j.1462-5822.2006.00712.x 16882035
27. Versatile suicide vectors which allow direct selection for gene replacement in gram-negative bacteria. Quandt J, Hynes MF, Gene 1993 127 15 21 10.1016/0378-1119(93)90611-6 8486283 (Pubitemid 23140440)
28. A broad host range mobilization system for the in vitro genetic engineering: transposon mutagenesis in gram negative bacteria. Simon R, Priefer U, Pehle A, Biotechnology 1983 1 784 890 10.1038/nbt1183-784
29. Genomic island 2 of Brucella melitensis is a major virulence determinant: Functional analyses of genomic islands. Rajashekara G, Covert J, Petersen E, Eskra L, Splitter G, J Bacteriol 2008 190 6243 6252 10.1128/JB.00520-08 18641138
30. Oy Growth Curves Ab Ltd. [ http://www.bioscreen.fi ]
31. Characterization of Brucella abortus and Brucella melitensis native haptens as outer membrane O-type polysaccharides independent from the smooth lipopolysaccharide. Aragón V, Díaz R, Moreno E, Moriyón I, J Bacteriol 1996 178 1070 1079 8576040 (Pubitemid 26048023)
32. Increases of efficacy as vaccine against Brucella abortus infection in mice by simultaneous inoculation with avirulent smooth bvrS/bvrR and rough wbkA mutants. Grilló MJ, Manterola L, De-Miguel MJ, Muñoz PM, Blasco JM, Moriyón I, Lopez-Goñi I, Vaccine 2006 24 2910 2916 10.1016/j.vaccine.2005.12.038 16439039
33. Bovine Brucellosis. OIE, Manual of Diagnostic Tests and Vaccines for Terrestrial Animals OIE 2009 1 35 Chapter 2.4.3
34. What have we learned from brucellosis in the mouse model? Grilló MJ, Blasco JM, Gorvel JP, Moriyón I, Moreno E, Vet Res 2012 43 29 10.1186/1297-9716-43-29 22500859
35. The nutrition of Brucellae. Gerhardt P, Bacteriol Rev 1958 22 91 98
36. Identification of Brucella melitensis vaccine strain Rev.1 by PCR-RFLP based on a mutation in the rpsL gene. Cloeckaert A, Grayon M, Grepinet O, Vaccine 2002 20 2546 2550 10.1016/S0264-410X(02)00159-7 12057611 (Pubitemid 34615594)
37. Compensatory adaptation to the deleterious effect of antibiotic resistance in Salmonella Typhimurium. Maisnier-Patin S, Berg OG, Liljas L, Andersson DI, Mol Microbiol 2002 46 355 366 10.1046/j.1365-2958.2002.03173.x 12406214 (Pubitemid 35340949)
38. Pathogenicity island integrase cross-talk: a potential new tool for virulence modulation. Manson JM, Gilmore MS, Mol Microbiol 2006 61 555 559 10.1111/j.1365-2958.2006.05262.x 16879637 (Pubitemid 44324082)